Active substances
Magnesium chloride + Sodium bicarbonate + Sodium chloride
- US FDA 2
- Health Canada 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NORMOCARB HF 25 | 0.21GM/100ML;2.8GM/100ML;9.07GM/100ML | solution · injection | DIALYSIS SUPS | Prescription | 26 Jul 2006 |
| NORMOCARB HF 35 | 0.21GM/100ML;3.97GM/100ML;8.3GM/100ML | solution · injection | DIALYSIS SUPS | Prescription | 26 Jul 2006 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| PRISM0CAL B22K0/0 | 02441691 | 7.14 G / L; 2.12 G / L; 3.05 G / L | SOLUTION · INTRAVENOUS; HAEMODIALYSIS | VANTIVE ULC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.